California Governor Announces $100m Insulin Initiative

State Will Produce Its Own Generic Biosimilar Products

 
• By Chloe Kent

California is set to begin producing its own biosimilar insulin products, having been designated $100m by state governor Gavin Newsom to complete the project.

Gavin Newsom
California Gov. Gavin Newsom's decision expands availability of CalRx brand OTC naloxone to all consumers who could potentially need the emergency treatment used in opioid overdose reversal. • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin